Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies, and Respiratory viral infections research.
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial
Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences
RSV F evolution escapes some monoclonal antibodies but does not strongly erode neutralization by human polyclonal sera
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
Age-dependent heterogeneity in the antigenic effects of mutations to influenza hemagglutinin
Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution
A neutralizing antibody prevents postfusion transition of measles virus fusion protein
Influenza A virus resistance to 4’-fluorouridine coincides with viral attenuation in vitro and in vivo
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback
Near-Universal Resistance to Macrolides of <i>Treponema pallidum</i> in North America
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
The harms of promoting the lab leak hypothesis for SARS-CoV-2 origins without evidence
Local-scale phylodynamics reveal differential community impact of SARS-CoV-2 in a metropolitan US county
Virology—the path forward
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials
Bright New Resources for Syphilis Research: Genetically Encoded Fluorescent Tags for <i>Treponema pallidum</i> and <scp>Sf1Ep</scp> Cells
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine
Author Correction: Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection
Exploring the Utility of Multiplex Infectious Disease Panel Testing for Diagnosis of Infection in Different Body Sites
Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
Virology under the Microscope—a Call for Rational Discourse
Respiratory syncytial virus and other respiratory virus infections in residents of homeless shelters – King County, Washington, 2019–2021
Prevalence and Predictors of Oral <i>Treponema pallidum</i> Detection by Quantitative Polymerase Chain Reaction in Early Syphilis
Molecular Methods for Identification of Microorganisms
De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity